SciELO - Scientific Electronic Library Online

vol.74 issue4Apnea, hypoxemia, and night sleep architecture in newborn preterm sample at Mexico CityExtralobar pulmonary sequestration asymptomatic and the importance of diagnosis and perinatal treatment: Expectant management is not a therapeutic option author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Neumología y cirugía de tórax

Print version ISSN 0028-3746


BARRETO-RODRIGUEZ, José O.; MEJIA, Mayra E.  and  BUENDIA-ROLDAN, Ivette. Current prospect of idiopathic pulmonary fibrosis in Mexico. Neumol. cir. torax [online]. 2015, vol.74, n.4, pp.256-261. ISSN 0028-3746.

IPF is a disease characterized by progressive and irreversible pulmonary fibrosis of unknown etiology, incidence and prevalence in the world is highly variable; in Mexico we have no representative epidemiological data. An inquiry was conducted of 419 pulmonologists, of which 168 responded pulmonologists around the country. On average each pulmonologist diagnosed 8 patients with IPF annually. Reference centers that recognize are INER 27%, 6% CMN IMSS, HGM 2%, 2% CEPREP, and 63% denied having reference center. For the diagnostic approach 89% has HRCT and 11% do not have it, 37% is support of an expert radiologist, 31% of an expert pathologist and 63% do not have these specialists. Regarding the initial treatment prescribed prednisone 85%, 46% n-acetilcisteine, 39% azatioprine. Colchicine 12% and 8% pirfenidone. With the results of this study we can conclude that Mexico needs not only train experts pulmonologists in interstitial diseases, it is also essential to increase the number of radiologists and expert pathologists in the subject and form an adequate network of national reference for obtain reliable epidemiological data.

Keywords : Idiopathic pulmonary fibrosis; Mexico; inquiry.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License